Combined Scutellarin and C18H17NO6 Imperils the Survival of Glioma: Partly Associated With the Repression of PSEN1/PI3K-AKT Signaling Axis
Glioma, the most common intracranial tumor, harbors great harm. Since the treatment for it has reached the bottleneck stage, the development of new drugs becomes a trend. Therefore, we focus on the effect of scutellarin (SCU) and its combination with C18H17NO6 (abbreviated as combination) on glioma...
Main Authors: | Xiu-Ying He, Yang Xu, Qing-Jie Xia, Xiao-Ming Zhao, Shan Li, Xiao-Qiong He, Ru-Rong Wang, Ting-Hua Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-09-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2021.663262/full |
Similar Items
-
Scutellarin inhibits the metastasis and cisplatin resistance in glioma cells
by: Tang S, et al.
Published: (2019-01-01) -
Systematic validation of variants of unknown significance in APP, PSEN1 and PSEN2
by: Simon Hsu, et al.
Published: (2020-06-01) -
APP, PSEN1, and PSEN2 Variants in Alzheimer’s Disease: Systematic Re-evaluation According to ACMG Guidelines
by: Xuewen Xiao, et al.
Published: (2021-06-01) -
An Efficient Chemical Synthesis of Scutellarein: An in Vivo Metabolite of Scutellarin
by: Ze-Xi Dong, et al.
Published: (2016-02-01) -
Anti-colorectal cancer effects of scutellarin revealed by genomic and proteomic analysis
by: Liu-Lin Xiong, et al.
Published: (2020-03-01)